Literatures

Primary Site >> Pancreatic Cancer

Gene >> MSLN

1.
Journal:	J Biol Chem. 1994 Jan 14;269(2):805-8.
Title:	A novel cytokine exhibiting megakaryocyte potentiating activity from a human pancreatic tumor cell line HPC-Y5.
Author:	Yamaguchi, N\|Hattori, K\|Oh-eda, M\|Kojima, T\|Imai, N\|Ochi, N
PMID:	8288629

2.
Journal:	J Biol Chem. 1995 Sep 15;270(37):21984-90.
Title:	Molecular cloning and expression of megakaryocyte potentiating factor cDNA.
Author:	Kojima, T\|Oh-eda, M\|Hattori, K\|Taniguchi, Y\|Tamura, M\|Ochi, N\|Yamaguchi, N
PMID:	7665620

3.
Journal:	Stem Cells. 1996;14 Suppl 1:62-74.
Title:	Characterization, molecular cloning and expression of megakaryocyte potentiating factor.
Author:	Yamaguchi, N\|Yamamura, Y\|Konishi, E\|Ueda, K\|Kojima, T\|Hattori, K\|Oheda, M\|Imai, N\|Taniguchi, Y\|Tamura, M\|Ochi, N
PMID:	11012204

4.
Journal:	Clin Cancer Res. 2001 Dec;7(12):3862-8.
Title:	Mesothelin is overexpressed in the vast majority of ductal adenocarcinomas of the pancreas: identification of a new pancreatic cancer marker by serial analysis of gene expression (SAGE).
Author:	Argani, P\|Iacobuzio-Donahue, C\|Ryu, B\|Rosty, C\|Goggins, M\|Wilentz, R E\|Murugesan, S R\|Leach, S D\|Jaffee, E\|Yeo, C J\|Cameron, J L\|Kern, S E\|Hruban, R H
PMID:	11751476

5.
Journal:	Cancer Res. 2003 Dec 15;63(24):8614-22.
Title:	Highly expressed genes in pancreatic ductal adenocarcinomas: a comprehensive characterization and comparison of the transcription profiles obtained from three major technologies.
Author:	Iacobuzio-Donahue, Christine A\|Ashfaq, Raheela\|Maitra, Anirban\|Adsay, N Volkan\|Shen-Ong, Grace L\|Berg, Karin\|Hollingsworth, Michael A\|Cameron, John L\|Yeo, Charles J\|Kern, Scott E\|Goggins, Michael\|Hruban, Ralph H
PMID:	14695172

6.
Journal:	Hum Pathol. 2004 Mar;35(3):357-66.
Title:	Analysis of novel tumor markers in pancreatic and biliary carcinomas using tissue microarrays.
Author:	Swierczynski, Sharon L\|Maitra, Anirban\|Abraham, Susan C\|Iacobuzio-Donahue, Christine A\|Ashfaq, Raheela\|Cameron, John L\|Schulick, Richard D\|Yeo, Charles J\|Rahman, Ayman\|Hinkle, David A\|Hruban, Ralph H\|Argani, Pedram
PMID:	15017593

7.
Journal:	BMC Cancer. 2004 May 12;4:19.
Title:	Characterization of human mesothelin transcripts in ovarian and pancreatic cancer.
Author:	Muminova, Zhanat E\|Strong, Theresa V\|Shaw, Denise R
PMID:	15140265

8.
Journal:
Title:	(111)In-Labeled CHX-A''-DTPA-conjugated MORAb-009, a chimeric monoclonal antibody directed against mesothelin
Author:	Chopra, Arvind
PMID:	22319803

9.
Journal:	Pancreas. 2005 May;30(4):349-54.
Title:	Expression of mesothelin mRNA in pure pancreatic juice from patients with pancreatic carcinoma, intraductal papillary mucinous neoplasm of the pancreas, and chronic pancreatitis.
Author:	Watanabe, Hiroyuki\|Okada, Gensaku\|Ohtsubo, Koushiro\|Yamaguchi, Yasushi\|Mouri, Hisatsugu\|Motoo, Yoshiharu\|Wakabayashi, Tokio\|Sawabu, Norio
PMID:	15841046

10.
Journal:	Clin Cancer Res. 2005 Sep 1;11(17):6342-51.
Title:	Identification of novel human CTL epitopes and their agonist epitopes of mesothelin.
Author:	Yokokawa, Junko\|Palena, Claudia\|Arlen, Philip\|Hassan, Raffit\|Ho, Mitchell\|Pastan, Ira\|Schlom, Jeffrey\|Tsang, Kwong Y
PMID:	16144939

11.
Journal:	Clin Cancer Res. 2006 Feb 1;12(3 Pt 1):827-31.
Title:	Diffuse mesothelin expression correlates with prolonged patient survival in ovarian serous carcinoma.
Author:	Yen, M Jim\|Hsu, Chih-Yi\|Mao, Tsui-Lien\|Wu, T-C\|Roden, Richard\|Wang, Tian-Li\|Shih, Ie-Ming
PMID:	16467095

12.
Journal:	Cancer Detect Prev. 2006;30(2):180-7.
Title:	Real-time detection of mesothelin in pancreatic cancer cell line supernatant using an acoustic wave immunosensor.
Author:	Corso, Christopher D\|Stubbs, Desmond D\|Lee, Sang-Hun\|Goggins, Michael\|Hruban, Ralph H\|Hunt, William D
PMID:	16647225

13.
Journal:	Clin Cancer Res. 2007 Sep 1;13(17):5144-9.
Title:	Phase I study of SS1P, a recombinant anti-mesothelin immunotoxin given as a bolus I.V. infusion to patients with mesothelin-expressing mesothelioma, ovarian, and pancreatic cancers.
Author:	Hassan, Raffit\|Bullock, Susie\|Premkumar, Ahalya\|Kreitman, Robert J\|Kindler, Hedy\|Willingham, Mark C\|Pastan, Ira
PMID:	17785569

14.
Journal:	Cancer Res. 2007 Oct 1;67(19):9055-65.
Title:	High cancer-specific expression of mesothelin (MSLN) is attributable to an upstream enhancer containing a transcription enhancer factor dependent MCAT motif.
Author:	Hucl, Tomas\|Brody, Jonathan R\|Gallmeier, Eike\|Iacobuzio-Donahue, Christine A\|Farrance, Iain K\|Kern, Scott E
PMID:	17909009

15.
Journal:	Clin Gastroenterol Hepatol. 2008 Dec;6(12):1425-31.
Title:	Immunostaining as an adjunct to cytology for diagnosis of pancreatic adenocarcinoma.
Author:	Agarwal, Banke\|Ludwig, Olivia J\|Collins, Brian T\|Cortese, Cherise
PMID:	19081530

16.
Journal:	Clin Transl Sci. 2008 Dec;1(3):228-39.
Title:	Effective depletion of regulatory T cells allows the recruitment of mesothelin-specific CD8 T cells to the antitumor immune response against a mesothelin-expressing mouse pancreatic adenocarcinoma.
Author:	Leao, Ihid C\|Ganesan, Priya\|Armstrong, Todd D\|Jaffee, Elizabeth M
PMID:	20357913

17.
Journal:	Cancer Biol Ther. 2008 Oct;7(10):1584-90. Epub 2008 Oct 3.
Title:	Nanoparticulate delivery of diphtheria toxin DNA effectively kills Mesothelin expressing pancreatic cancer cells.
Author:	Showalter, Shayna L\|Huang, Yu-Hung\|Witkiewicz, Agneszka\|Costantino, Christina L\|Yeo, Charles J\|Green, Jordan J\|Langer, Robert\|Anderson, Daniel G\|Sawicki, Janet A\|Brody, Jonathan R
PMID:	19039293

18.
Journal:	Oncol Rep. 2008 Dec;20(6):1375-80.
Title:	Secretion of N-ERC/mesothelin and expression of C-ERC/mesothelin in human pancreatic ductal carcinoma.
Author:	Inami, Koichi\|Kajino, Kazunori\|Abe, Masaaki\|Hagiwara, Yoshiaki\|Maeda, Masahiro\|Suyama, Masafumi\|Watanabe, Sumio\|Hino, Okio
PMID:	19020717

19.
Journal:	Mol Cancer Ther. 2008 Feb;7(2):286-96.
Title:	Mesothelin is a malignant factor and therapeutic vaccine target for pancreatic cancer.
Author:	Li, Min\|Bharadwaj, Uddalak\|Zhang, Rongxin\|Zhang, Sheng\|Mu, Hong\|Fisher, William E\|Brunicardi, F Charles\|Chen, Changyi\|Yao, Qizhi
PMID:	18281514

20.
Journal:	Mol Cancer Res. 2008 Nov;6(11):1755-65.
Title:	Mesothelin-induced pancreatic cancer cell proliferation involves alteration of cyclin E via activation of signal transducer and activator of transcription protein 3.
Author:	Bharadwaj, Uddalak\|Li, Min\|Chen, Changyi\|Yao, Qizhi
PMID:	19010822

21.
Journal:	Biochem Biophys Res Commun. 2009 Dec 18;390(3):636-41.
Title:	An animal model of preclinical diagnosis of pancreatic ductal adenocarcinomas.
Author:	Fukamachi, Katsumi\|Tanaka, Hajime\|Hagiwara, Yoshiaki\|Ohara, Hirotaka\|Joh, Takashi\|Iigo, Masaaki\|Alexander, David B\|Xu, Jiegou\|Long, Ne\|Takigahira, Misato\|Yanagihara, Kazuyoshi\|Hino, Okio\|Saito, Izumu\|Tsuda, Hiroyuki
PMID:	19818733

22.
Journal:	Clin Cancer Res. 2009 Nov 1;15(21):6511-8.
Title:	Circulating mesothelin protein and cellular antimesothelin immunity in patients with pancreatic cancer.
Author:	Johnston, Fabian Mc\|Tan, Marcus C B\|Tan, Benjamin R Jr\|Porembka, Matthew R\|Brunt, Elizabeth M\|Linehan, David C\|Simon, Peter O Jr\|Plambeck-Suess, Stacey\|Eberlein, Timothy J\|Hellstrom, Karl Erik\|Hellstrom, Ingegerd\|Hawkins, William G\|Goedegebuure, Peter
PMID:	19843662

23.
Journal:	Int J Mol Med. 2010 Aug;26(2):185-91.
Title:	Suppression of cell death by the secretory form of N-terminal ERC/mesothelin.
Author:	Wang, Tegexibaiyin\|Kajino, Kazunori\|Abe, Masaaki\|Tan, Ke\|Maruo, Masumi\|Sun, Guodong\|Hagiwara, Yoshiaki\|Maeda, Masahiro\|Hino, Okio
PMID:	20596597

24.
Journal:	Int J Cancer. 2011 May 1;128(9):2020-30.
Title:	A novel high-affinity human monoclonal antibody to mesothelin.
Author:	Ho, Mitchell\|Feng, Mingqian\|Fisher, Robert J\|Rader, Christoph\|Pastan, Ira
PMID:	20635390

25.
Journal:	J Biol Chem. 2011 Apr 8;286(14):11960-9.
Title:	Structural analysis of the cancer-specific promoter in mesothelin and in other genes overexpressed in cancers.
Author:	Ren, Yunzhao R\|Patel, Kalpesh\|Paun, Bogdan C\|Kern, Scott E
PMID:	21288909

26.
Journal:	Cancer Lett. 2011 Jun 1;305(1):32-9.
Title:	Dendritic cells adenovirally-transduced with full-length mesothelin cDNA elicit mesothelin-specific cytotoxicity against pancreatic cancer cell lines in vitro.
Author:	Miyazawa, Motoki\|Iwahashi, Makoto\|Ojima, Toshiyasu\|Katsuda, Masahiro\|Nakamura, Masaki\|Nakamori, Mikihito\|Ueda, Kentaro\|Naka, Teiji\|Hayata, Keiji\|Iida, Takeshi\|Yamaue, Hiroki
PMID:	21397388

27.
Journal:	Carcinogenesis. 2011 Jul;32(7):1013-24.
Title:	Mesothelin overexpression promotes autocrine IL-6/sIL-6R trans-signaling to stimulate pancreatic cancer cell proliferation.
Author:	Bharadwaj, Uddalak\|Marin-Muller, Christian\|Li, Min\|Chen, Changyi\|Yao, Qizhi
PMID:	21515913

28.
Journal:	Mol Cancer. 2011 Aug 31;10:106.
Title:	Mesothelin confers pancreatic cancer cell resistance to TNF-alpha-induced apoptosis through Akt/PI3K/NF-kappaB activation and IL-6/Mcl-1 overexpression.
Author:	Bharadwaj, Uddalak\|Marin-Muller, Christian\|Li, Min\|Chen, Changyi\|Yao, Qizhi
PMID:	21880146

29.
Journal:	Clin Chem Lab Med. 2012 Apr;50(4):721-5.
Title:	Serum mesothelin and megakaryocyte potentiating factor in pancreatic and biliary cancers.
Author:	Sharon, Elad\|Zhang, Jingli\|Hollevoet, Kevin\|Steinberg, Seth M\|Pastan, Ira\|Onda, Masanori\|Gaedcke, Jochen\|Ghadimi, B Michael\|Ried, Thomas\|Hassan, Raffit
PMID:	22149739

30.
Journal:	Cancer Sci. 2012 Apr;103(4):739-46.
Title:	Coexpression of MUC16 and mesothelin is related to the invasion process in pancreatic ductal adenocarcinoma.
Author:	Shimizu, Atsushi\|Hirono, Seiko\|Tani, Masaji\|Kawai, Manabu\|Okada, Ken-Ichi\|Miyazawa, Motoki\|Kitahata, Yuji\|Nakamura, Yasushi\|Noda, Tetsuo\|Yokoyama, Shozo\|Yamaue, Hiroki
PMID:	22320398

31.
Journal:	Pancreatology. 2012 Jan-Feb;12(1):27-34.
Title:	Gene expression signature of advanced pancreatic ductal adenocarcinoma using low density array on endoscopic ultrasound-guided fine needle aspiration samples.
Author:	Bournet, B\|Pointreau, A\|Souque, A\|Oumouhou, N\|Muscari, F\|Lepage, B\|Senesse, P\|Barthet, M\|Lesavre, N\|Hammel, P\|Levy, P\|Ruszniewski, P\|Cordelier, P\|Buscail, L
PMID:	22487470

32.
Journal:	PLoS One. 2012;7(7):e40157.
Title:	A novel survival-based tissue microarray of pancreatic cancer validates MUC1 and mesothelin as biomarkers.
Author:	Winter, Jordan M\|Tang, Laura H\|Klimstra, David S\|Brennan, Murray F\|Brody, Jonathan R\|Rocha, Flavio G\|Jia, Xiaoyu\|Qin, Li-Xuan\|D'Angelica, Michael I\|DeMatteo, Ronald P\|Fong, Yuman\|Jarnagin, William R\|O'Reilly, Eileen M\|Allen, Peter J
PMID:	22792233

33.
Journal:	Int J Nanomedicine. 2012;7:5053-65.
Title:	A MSLN-targeted multifunctional nanoimmunoliposome for MRI and targeting therapy in pancreatic cancer.
Author:	Deng, Li\|Ke, Xingfa\|He, Zhiying\|Yang, Daoqiu\|Gong, Hai\|Zhang, Yingying\|Jing, Xiaolong\|Yao, Jianzhong\|Chen, Jianming
PMID:	23028227

34.
Journal:	Clin Cancer Res. 2013 Nov 1;19(21):5901-13.
Title:	A tumorigenic factor interactome connected through tumor suppressor microRNA-198 in human pancreatic cancer.
Author:	Marin-Muller, Christian\|Li, Dali\|Bharadwaj, Uddalak\|Li, Min\|Chen, Changyi\|Hodges, Sally E\|Fisher, William E\|Mo, Qianxing\|Hung, Mien-Chie\|Yao, Qizhi
PMID:	23989979

35.
Journal:	Anal Quant Cytopathol Histpathol. 2013 Jun;35(3):157-62.
Title:	Pancreatic metastases of renal clear cell carcinoma: a clinicopathological study of 11 cases with special emphasis on the usefulness of PAX2 and mesothelin for the distinction from primary ductal adenocarcinoma of the pancreas.
Author:	Gnemmi, Viviane\|Leroy, Xavier\|Triboulet, Jean-Pierre\|Pruvot, Francois-Rene\|Villers, Arnauld\|Leteurtre, Emmanuelle\|Buob, David
PMID:	24344503

36.
Journal:	Anticancer Agents Med Chem. 2013 Feb;13(2):276-80.
Title:	The role of mesothelin in tumor progression and targeted therapy.
Author:	Tang, Zhewei\|Qian, Min\|Ho, Mitchell
PMID:	22721387

37.
Journal:	Sci Rep. 2013;3:1870.
Title:	Mesothelin binding to CA125/MUC16 promotes pancreatic cancer cell motility and invasion via MMP-7 activation.
Author:	Chen, Shih-Hsun\|Hung, Wei-Chien\|Wang, Pu\|Paul, Colin\|Konstantopoulos, Konstantinos
PMID:	23694968

38.
Journal:	Int J Cancer. 2013 Jul;133(1):88-97.
Title:	Intravenous genetic mesothelin vaccine based on human adenovirus 40 inhibits growth and metastasis of pancreatic cancer.
Author:	Yamasaki, Satoshi\|Miura, Yoshiaki\|Davydova, Julia\|Vickers, Selwyn M\|Yamamoto, Masato
PMID:	23233329

39.
Journal:	PLoS One. 2013 Jul 9;8(7):e68303.
Title:	Mesothelin virus-like particle immunization controls pancreatic cancer growth through CD8+ T cell induction and reduction in the frequency of CD4+ foxp3+ ICOS- regulatory T cells.
Author:	Zhang, Sheng\|Yong, Lin-Kin\|Li, Dali\|Cubas, Rafael\|Chen, Changyi\|Yao, Qizhi
PMID:	23874581

40.
Journal:	HPB (Oxford). 2014 Jul;16(7):670-6.
Title:	Serum IGFBP2 and MSLN as diagnostic and prognostic biomarkers for pancreatic cancer.
Author:	Kendrick, Zachary W\|Firpo, Matthew A\|Repko, Robert C\|Scaife, Courtney L\|Adler, Douglas G\|Boucher, Kenneth M\|Mulvihill, Sean J
PMID:	24308545

41.
Journal:	PLoS One. 2014 Jan 21;9(1):e85935.
Title:	MSLN gene silencing has an anti-malignant effect on cell lines overexpressing mesothelin deriving from malignant pleural mesothelioma.
Author:	Melaiu, Ombretta\|Stebbing, Justin\|Lombardo, Ylenia\|Bracci, Elisa\|Uehara, Norihisa\|Bonotti, Alessandra\|Cristaudo, Alfonso\|Foddis, Rudy\|Mutti, Luciano\|Barale, Roberto\|Gemignani, Federica\|Giamas, Georgios\|Landi, Stefano
PMID:	24465798

42.
Journal:	Hepatobiliary Pancreat Dis Int. 2014 Aug;13(4):371-80.
Title:	Interleukin-6: a villain in the drama of pancreatic cancer development and progression.
Author:	Holmer, Reinhild\|Goumas, Freya A\|Waetzig, Georg H\|Rose-John, Stefan\|Kalthoff, Holger
PMID:	25100121

43.
Journal:	Mol Cancer Ther. 2014 Nov;13(11):2630-40.
Title:	An antimesothelin-monomethyl auristatin e conjugate with potent antitumor activity in ovarian, pancreatic, and mesothelioma models.
Author:	Scales, Suzie J\|Gupta, Nidhi\|Pacheco, Glenn\|Firestein, Ron\|French, Dorothy M\|Koeppen, Hartmut\|Rangell, Linda\|Barry-Hamilton, Vivian\|Luis, Elizabeth\|Chuh, Josefa\|Zhang, Yin\|Ingle, Gladys S\|Fourie-O'Donohue, Aimee\|Kozak, Katherine R\|Ross, Sarajane\|Dennis, M
PMID:	25249555

44.
Journal:	Int J Clin Exp Med. 2014 Nov 15;7(11):4000-7. eCollection 2014.
Title:	Diagnostic value of mesothelinin pancreatic cancer: a meta-analysis.
Author:	Zhu, Lin\|Liu, Yiling\|Chen, Guangyuan
PMID:	25550908

45.
Journal:	Mol Cancer Res. 2015 Mar;13(3):439-48.
Title:	MUC1 Promoter-Driven DTA as a Targeted Therapeutic Strategy against Pancreatic Cancer.
Author:	Tholey, Renee M\|Lal, Shruti\|Jimbo, Masaya\|Burkhart, Richard A\|Blanco, Fernando F\|Cozzitorto, Joseph A\|Eisenberg, Josh D\|Jiang, Wei\|Iacobuzio-Donahue, Christine A\|Witkiewicz, Agnieszka K\|Glbert, Melissa\|Yeo, Charles J\|Brody, Jonathan R\|Sawicki, Janet A\|Win
PMID:	25336517

46.
Journal:	Oncotarget. 2015 Feb 28;6(6):4496-504.
Title:	Safety and biodistribution of 111In-amatuximab in patients with mesothelin expressing cancers using single photon emission computed tomography-computed tomography (SPECT-CT) imaging.
Author:	Lindenberg, Liza\|Thomas, Anish\|Adler, Stephen\|Mena, Esther\|Kurdziel, Karen\|Maltzman, Julia\|Wallin, Bruce\|Hoffman, Kimberly\|Pastan, Ira\|Paik, Chang Hum\|Choyke, Peter\|Hassan, Raffit
PMID:	25756664

47.
Journal:	PLoS One. 2015 Mar 24;10(3):e0122462.
Title:	Methylation-associated partial down-regulation of mesothelin causes resistance to anti-mesothelin immunotoxins in a pancreatic cancer cell line.
Author:	Hollevoet, Kevin\|Mason-Osann, Emily\|Muller, Fabian\|Pastan, Ira
PMID:	25803818

48.
Journal:	J Immunol Res. 2015;2015:268172.
Title:	A novel PET imaging using (6)(4)Cu-labeled monoclonal antibody against mesothelin commonly expressed on cancer cells.
Author:	Kobayashi, Kazuko\|Sasaki, Takanori\|Takenaka, Fumiaki\|Yakushiji, Hiromasa\|Fujii, Yoshihiro\|Kishi, Yoshiro\|Kita, Shoichi\|Shen, Lianhua\|Kumon, Hiromi\|Matsuura, Eiji
PMID:	25883990

49.
Journal:	Oncotarget. 2015 Dec 8;6(39):42081-90.
Title:	Imaging the distribution of an antibody-drug conjugate constituent targeting mesothelin with (8)(9)Zr and IRDye 800CW in mice bearing human pancreatic tumor xenografts.
Author:	ter Weele, Eva J\|Terwisscha van Scheltinga, Anton G T\|Kosterink, Jos G W\|Pot, Linda\|Vedelaar, Silke R\|Lamberts, Laetitia E\|Williams, Simon P\|Lub-de Hooge, Marjolijn N\|de Vries, Elisabeth G E
PMID:	26536664

50.
Journal:	J Exp Clin Cancer Res. 2016 Mar 1;35:39.
Title:	Murine mesothelin: characterization, expression, and inhibition of tumor growth in a murine model of pancreatic cancer.
Author:	Zervos, Emmanuel\|Agle, Steven\|Freistaedter, Andrew G\|Jones, Gwendolyn J B\|Roper, Rachel L
PMID:	26931187

51.
Journal:	J Clin Oncol. 2016 Dec;34(34):4171-4179.
Title:	Mesothelin Immunotherapy for Cancer: Ready for Prime Time?
Author:	Hassan, Raffit\|Thomas, Anish\|Alewine, Christine\|Le, Dung T\|Jaffee, Elizabeth M\|Pastan, Ira
PMID:	27863199

52.
Journal:	Virchows Arch. 2016 Nov;469(5):523-532.
Title:	Distinct pathways of pathogenesis of intraductal oncocytic papillary neoplasms and intraductal papillary mucinous neoplasms of the pancreas.
Author:	Basturk, Olca\|Chung, Sun M\|Hruban, Ralph H\|Adsay, N Volkan\|Askan, Gokce\|Iacobuzio-Donahue, Christine\|Balci, Serdar\|Zee, Sui Y\|Memis, Bahar\|Shia, Jinru\|Klimstra, David S
PMID:	27591765

53.
Journal:	World J Gastrointest Pathophysiol. 2016 May 15;7(2):218-22.
Title:	Clinical impacts of mesothelin expression in gastrointestinal carcinomas.
Author:	Einama, Takahiro\|Kawamata, Futoshi\|Kamachi, Hirofumi\|Nishihara, Hiroshi\|Homma, Shigenori\|Matsuzawa, Fumihiko\|Mizukami, Tatsuzo\|Konishi, Yuji\|Tahara, Munenori\|Kamiyama, Toshiya\|Hino, Okio\|Taketomi, Akinobu\|Todo, Satoru
PMID:	27190694

54.
Journal:	Pathol Res Pract. 2016 Apr;212(4):288-93.
Title:	Diagnostic value of IMP3 and mesothelin in differentiating pancreatic ductal adenocarcinoma from chronic pancreatitis.
Author:	Ibrahim, Doaa Abdelaziz\|Abouhashem, Nehal S
PMID:	26874572

55.
Journal:	Cancer Discov. 2016 Jan;6(1):8.
Title:	T Cells Target Pancreatic Tumors.
Author:	Leslie, Mitch
PMID:	26626535

56.
Journal:	Oncotarget. 2017 Feb 7;8(6):9189-9199.
Title:	Mesothelin-targeted immunotoxin RG7787 has synergistic anti-tumor activity when combined with taxanes.
Author:	Kolyvas, Emily\|Rudloff, Michael\|Poruchynsky, Marianne\|Landsman, Rebekah\|Hollevoet, Kevin\|Venzon, David\|Alewine, Christine
PMID:	27999204

57.
Journal:	Onco Targets Ther. 2017 Nov 8;10:5337-5353.
Title:	Amatuximab and novel agents targeting mesothelin for solid tumors.
Author:	Baldo, Paolo\|Cecco, Sara
PMID:	29184420

58.
Journal:	Int J Radiat Oncol Biol Phys. 2018 Feb 1;100(2):486-489.
Title:	Multiplex Proximity Ligation Assay to Identify Potential Prognostic Biomarkers for Improved Survival in Locally Advanced Pancreatic Cancer Patients Treated With Stereotactic Body Radiation Therapy.
Author:	Rao, Avani D\|Liu, Yufei\|von Eyben, Rie\|Hsu, Charles C\|Hu, Chen\|Rosati, Lauren M\|Parekh, Arti\|Ng, Kendall\|Hacker-Prietz, Amy\|Zheng, Lei\|Pawlik, Timothy M\|Laheru, Daniel A\|Jaffee, Elizabeth M\|Weiss, Matthew J\|Le, Dung T\|Hruban, Ralph H\|De Jesus-Acosta, Ana\|
PMID:	29157747

59.
Journal:	PLoS One. 2018 Feb 23;13(2):e0193131.
Title:	Development of improved therapeutic mesothelin-based vaccines for pancreatic cancer.
Author:	White, Michael\|Freistaedter, Andrew\|Jones, Gwendolyn J B\|Zervos, Emmanuel\|Roper, Rachel L
PMID:	29474384

60.
Journal:	Pancreatology. 2018 Jun;18(4):458-462.
Title:	Measurement of indicator genes using global complementary DNA (cDNA) amplification, by polyadenylic acid reverse transcriptase polymerase chain reaction (poly A RT-PCR): A feasibility study using paired samples from tissue and ductal juice in patients und
Author:	Sanyal, Sudip\|Siriwardena, Ajith K\|Byers, Richard
PMID:	29574096

61.
Journal:	PLoS One. 2018 May 8;13(5):e0197029.
Title:	Fn3 proteins engineered to recognize tumor biomarker mesothelin internalize upon binding.
Author:	Sirois, Allison R\|Deny, Daniela A\|Baierl, Samantha R\|George, Katia S\|Moore, Sarah J
PMID:	29738555

62.
Journal:	Oncotarget. 2018 Apr 27;9(32):22451-22459.
Title:	Prediction of improved survival in patients with pancreatic cancer via IL-21 enhanced detection of mesothelin epitope-reactive T-cell responses.
Author:	Meng, Qingda\|Valentini, Davide\|Rao, Martin\|Liu, Zhenjiang\|Xie, Shanshan\|Morgell, Ann\|Dodoo, Ernest\|Lohr, Matthias\|Rangelova, Elena\|Del Chiaro, Marco\|Ernberg, Ingemar\|Maeurer, Markus
PMID:	29854291

63.
Journal:	Cell Immunol. 2018 Jul;329:31-40.
Title:	Engineered CAR T cells targeting mesothelin by piggyBac transposon system for the treatment of pancreatic cancer.
Author:	He, Jiangchuan\|Zhang, Zhiwei\|Lv, Saiqun\|Liu, Xiangzhen\|Cui, Lianzhen\|Jiang, Duqing\|Zhang, Qi\|Li, Linfang\|Qin, Wenxia\|Jin, Huajun\|Qian, Qijun
PMID:	29859625

64.
Journal:	J Hematol Oncol. 2018 Aug 13;11(1):102.
Title:	Recombination of a dual-CAR-modified T lymphocyte to accurately eliminate pancreatic malignancy.
Author:	Zhang, Erhao\|Yang, Peiwei\|Gu, Jieyi\|Wu, Heming\|Chi, Xiaowei\|Liu, Chen\|Wang, Ying\|Xue, Jianpeng\|Qi, Weiyan\|Sun, Qingbo\|Zhang, Shengnan\|Hu, Jialiang\|Xu, Hanmei
PMID:	30103775

65.
Journal:	Arch Gynecol Obstet. 2018 Oct 15. pii: 10.1007/s00404-018-4933-z.
Title:	Mesothelin as a target for cervical cancer therapy.
Author:	Johrens, Korinna\|Lazzerini, Lea\|Barinoff, Jana\|Sehouli, Jalid\|Cichon, Guenter
PMID:	30324544

66.
Journal:	Oncotarget. 2018 Sep 18;9(73):33844-33852.
Title:	The anti-mesothelin monoclonal antibody amatuximab enhances the anti-tumor effect of gemcitabine against mesothelin-high expressing pancreatic cancer cells in a peritoneal metastasis mouse model.
Author:	Mizukami, Tatsuzo\|Kamachi, Hirofumi\|Fujii, Yuki\|Matsuzawa, Fumihiko\|Einama, Takahiro\|Kawamata, Futoshi\|Kobayashi, Nozomi\|Hatanaka, Yutaka\|Taketomi, Akinobu
PMID:	30333914